Even without the approval of the Food and Drug Administration, Medicare has expanded its coverage of drugs for cancer treatment. The push for these drugs have mostly come from doctors who believe these treatments, known as off-label uses are essential for the treatment of cancer in patients. These drugs are the most up-to-date care. Though the drugs have limited evidence that they are effective, doctors are using them on critical patients as a last hope.
People and doctors for the drug changes in the Medicare rules believe that the spending is worth it because if the drugs work, it can enhance the understanding of which drugs work and which don’t against various forms of cancer. Opponents of the changes believe that it is a waste of money and can expose people to side effects that are not known and not approved by the FDA. They also believe that doctors are using patients as guinea pigs for unproved drugs and therapies.
Medicare officials have also canceled an analysis of the costs of these changes so predictions of the amount being spent on these drugs are hard to determine. One of the products called Gemzar, costs $2,500 to $5,000 a month. The new rules can guarantee Medicare to use the drugs for many types of cancer even though the FDA has only approved it for use on 4 types of cancer.
A spokesman for the Pharmaceutical Research and Manufacturers of America said the new rules ensured “that cancer patients have access to the treatments they need.” Like this man, doctors think that they need greater flexibility since getting a drug approved can take years. Some of these people don’t have years to spare and are willing to try any drug that may help them.





